South Korea Mucopolysaccharidosis Treatment Market Analysis

$3,500.00$7,500.00

  • Type: Rare Disease Area
  • Published : June 2021
  • Region: Asia
  • Country: South Korea
  • Report ID : 4966

  • Format: PPT, PDF

South Korea Mucopolysaccharidosis Treatment Market: Segmented By Treatment Type (Enzyme Replacement Therapy, Hematopoietic Stem Cell therapy [HSCT]) and By Route Of Administration (Intravenous and Intracerebroventricular [ICV])- Growth, Trends and Forecasts (2020 – 2028)

Clear

Report Overview

The South Korea Mucopolysaccharidosis treatment market size stood at around USD xx billion in 2020 and is projected to reach xx billion by 2028, exhibiting a CAGR of around xx% during the forecast period.

Mucopolysaccharidoses (MPSs) are a group of inherited metabolic diseases, which are a result of deficiencies in specific lysosomal enzymes that are required for the degradation of glycosaminoglycans (GAGs). It is known that there are eleven genes are causally related to MPS. Deficiency in a specific enzyme results in the accumulation of undegraded GAGs, which causes progressive damage to cells, tissues, and organs. MPS has a broad spectrum of clinical presentations with varied severity and prognosis for different types and individuals. MPS disorders are autosomal recessive, except for MPS II (Hunter syndrome), which has X‐linked inheritance and mainly affects males.

The prevalence of MPS in South Korea population is around 1.35 per 100,000. MPS II is the most prevalent type of MPS (54.6%), followed by MPS III (18.4%), MPS I (15.3%), MPS IV (9.5%), and MPS VI (1.4%).

Market Drivers

The lack of presence of wide range of therapeutics for the patients has led to the domination of enzyme replacement therapy. For instance, Elaprase is the most commonly and widely used drug for mucopolysaccharidosis type II (Hunter Syndrome). Expected launch of cheaper alternatives and advanced therapeutics is likely to drive the growth of South Korea’s MPS treatment market. There are a significant number of pipeline candidates for the development of advanced therapeutics for various types of MPS by global players, this will further propel the market drive. High cost of therapeutics along with poor diagnosis rates restrain the market growth.

 

1. South Korea Mucopolysaccharidosis Treatment Market Overview……..
A. Market Size
2. Market Growth Drivers……………………………………………….
A. Need for Advanced Therapeutics
B. Significant Number Of Pipeline Candidates
3. Types Of Mucopolysaccharidosis……………………………………….
A. Type I
B. Type II
C. Type III
D. Type IV
E. Type VI
F. Type VII
G. Type IX
4. Mucopolysaccharidosis Treatment Market Segmentation……………
A. Treatment Type
I. Enzyme Replacement Therapy
II. Hematopoietic Stem Cell therapy (HSCT)
B. Route Of Administration
I. Intravenous
II. Intracerebroventricular (ICV)
5. Mucopolysaccharidosis Treatment Market Share……………………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………….
A. BioMarin Company Overview, Product & Services, Strategies & Financials
B. Takeda Pharmaceuticals Korea Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………
A. New Trends and Development of Mucopolysaccharidosis Treatment Market
B. Future Opportunities
10. Conclusion

 

 

Market Segmentation

By Treatment Type:

Hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT) are the main treatments for MPS disorders. HSCT is now the only therapy to prevent progressive neurodegenerative disorders in MPS I, II and VII. ERT is currently available for MPS I, II, IVA, VI, and VII, and it has been demonstrated to substantially reduce urinary GAG levels and significantly improve endurance, physiological activities, joint mobility, and quality of life. Additional therapies for MPS disorders are currently in clinical trials, and these include chaperone therapy, substrate reduction therapy, and gene therapy.

By Route of Administration:

According to route of administration market is segmented into intravenous and intracerebroventricular.

Top Players

Some of the key players operating in the MPS treatment market include Takeda Pharmaceutical, BioMarin Pharmaceuticals, Sarepta Therapeutics, GC Pharma, and others. Naglazyme (galsulfase) by BioMarin Pharmaceutical for the treatment of MPS type VI and Elaprase (idursulfase) by Takeda Pharmaceuticals for the treatment of MPS type II hold the monopoly in South Korea market.

 

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements